Pregled bibliografske jedinice broj: 212449
Nm23-H1 and colon adenocarcinoma
Nm23-H1 and colon adenocarcinoma // 10th International Congress of Human Genetics : abstracts ; u: European Journal of Human Genetics / ICHG (ur.).
Beč: Nature publishing group, 2001. str. 101-101 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 212449 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Nm23-H1 and colon adenocarcinoma
Autori
Kapitanović, Sanja ; Čačev, Tamara ; Radošević, Senka ; Berković, Maja ; Pavelić, Krešimir ; Spaventi, Radan.
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
10th International Congress of Human Genetics : abstracts ; u: European Journal of Human Genetics
/ ICHG - Beč : Nature publishing group, 2001, 101-101
Skup
International Congress of Human Genetics (10 ; 2001)
Mjesto i datum
Beč, Austrija, 15.05.2001. - 19.05.2001
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
nm23-H1; colon adenocarcinoma
Sažetak
Nm32 gene was originally identified by differential hybridisation of K-1735 melanoma cell line clones of varying metastatic potential. A tumor metastases-supressor function was implicated by the reduced expression of nm23 in highly metastatic sublines compared with non-metastatic sublines derived from the same K-1735 clone. The purpose of this study was to evaluate whether the expression of the nm23-H1 protein or loss of heterozygosity (LOH) of the nm23-H1 gene is associated with tumor stage and grade of tumor differentiation. We also investigated the correlation of nm23-H1 expression with 5-year survival. Of 102 adenocarcinomas that were examined, 41% showed a weak positive immunostaining for nm23-H1 protein. The most nm23-H1 positive tumors were in Dukes' B (67%) and in the well differentiated tumors (65%). Statistical analysis showed that there was no statistically significant difference in survival between the patients with nm23-H1 positive tumors and patients with tumors that were not stained for nm23-H1 protein. To analyze LOH at the nm23-H1 gene we used VNTR marker located in untranslated 5' region of the nm23-H1. At this nm23-H1 locus 60% of samples were informative and 33% of them demonstrated LOH. The nm23-H1 was more frequent in tumors that were larger than 5 cm than in smaller ones. Positive correlation was found between the nm23-H1 LOH and histological grade as well as between the nm23-H1 LOH and Dukes' stage of tumor samples.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
0098108
Ustanove:
Pliva-Istraživački institut,
Institut "Ruđer Bošković", Zagreb
Profili:
Krešimir Pavelić
(autor)
Sanja Kapitanović
(autor)
Senka Radošević
(autor)
Tamara Čačev
(autor)
Radan Spaventi
(autor)
Maja Cigrovski Berković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE